PHS:FRA
Photocure ASA
€4.58
arrow_upward
+1.44%(+0.065) 1D
Oct 19, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PHS...
Open
€4.58
High
€4.58
Low
€4.58
Avg. vol.
0.00
Volume
0.00
52-wk high
€6.71
52-wk low
€4.28
No. of employees
100
Open
€4.58
High
€4.58
Low
€4.58
Avg. vol.
0.00
Volume
0.00
52-wk high
€6.71
52-wk low
€4.28
No. of employees
100
News stories
From web sources and news partners
Bloomberg
·
34 minutes ago
US Stock Futures Edge Higher After Chipmaker Rally: Markets Wrap
TradingView
·
33 minutes ago
Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50-Day Line
BBN Times
·
58 minutes ago
S&P 500 Rises to 7,690.73 as Tech and AI Stocks Rebound From Worst Week Since June Amid US-Iran Negotiations
Investing.com
·
2 hours ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.07%
Profile
Photocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. Photocure's strategy in cancer is to continue the commercialization of Hexvix for bladder cancer diagnostics, and continue the development of the cancer portfolio and out-license prior to phase III studies. This strategy is based on a strong platform of intellectual property in photodynamic therapy. Wikipedia
About Photocure ASA